VaxCAR 001
Alternative Names: VAX-CAR-T; VaxCAR001Latest Information Update: 18 Jul 2024
At a glance
- Originator Vaxcell-Bio Therapeutics
- Class Cell therapies; Immunotherapies; T lymphocyte cell therapies
- Mechanism of Action Immunologic cytotoxicity; Immunomodulators
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity No
Highest Development Phases
- Preclinical Solid tumours